Jeyakantha Ratnasingam

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes

Suresh Chandran, Wei Lin Tay, Weng Kit Lye et al. · Diabetes Technology & Therapeutics · 2018 · 118 citations

Medicine, Endocrinology, Internal Medicine +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Continuous glucose monitoring results in lower HbA_1c in Malaysian women with insulin‐treated gestational diabetes: a randomized controlled trial

Sharmila Paramasivam, Karuthan Chinna, Awadhesh Kumar Singh et al. · Diabetic Medicine · 2018 · 68 citations

Medicine, Endocrinology, Maternal Health +17

Glucocorticoids suppress brown adipose tissue function in humans: A double‐blind placebo‐controlled study

Moe Thuzar, Weikiat Phillip Law, Jeyakantha Ratnasingam et al. · Diabetes Obesity and Metabolism · 2017 · 53 citations

Life Sciences, Endocrinology, Nutritional Sciences +16